Baltimore, MD, United States of America

Rebecca D Goldfarb


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Baltimore, MD (US) (1981)
  • Howell, NJ (US) (1985)

Company Filing History:


Years Active: 1981-1985

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Rebecca D Goldfarb

Introduction

Rebecca D Goldfarb is a notable inventor based in Baltimore, MD. She has made significant contributions to the field of biochemistry, particularly in the development of assays for alpha-amylase. With a total of two patents to her name, her work has implications in medical diagnostics and enzymatic reactions.

Latest Patents

Rebecca's latest patents include an innovative alpha-amylase assay and substrates for use therein. This invention involves a maltodextrin phosphorylase limit dextrin in the presence of maltodextrin phosphorylase and inorganic phosphate. This substrate is utilized for alpha-amylase, initiating a series of enzymatic reactions that result in a chromogen response. This response can be used to measure the concentration of alpha-amylase in body fluids. Additionally, a novel limit dextrin and its preparation are described in her patents.

Career Highlights

Throughout her career, Rebecca has worked with prominent companies such as Cooper Biomedical, Inc. and Worthington Biochemical Corporation. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in her field.

Collaborations

Rebecca has collaborated with notable colleagues, including Paul T Nix and Linda J Stong. These partnerships have fostered an environment of innovation and creativity in her work.

Conclusion

Rebecca D Goldfarb's contributions to the field of biochemistry through her patents and collaborations highlight her role as a significant inventor. Her work continues to impact medical diagnostics and enzymatic research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…